Opus Genetics, Inc. (IRD)
4.80
-0.17
(-3.42%)
USD |
NASDAQ |
May 15, 16:00
4.805
0.00 (0.00%)
After-Hours: 20:00
Opus Genetics Shareholders Equity (Quarterly) : -45.84M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 285.63M |
| Xilio Therapeutics, Inc. | 72.54M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.79M |
| Total Liabilities (Quarterly) | 112.62M |
| Debt to Equity Ratio | -0.5658 |
| Current Ratio | 7.131 |
| Net Debt Paydown Yield | -0.44% |